Baidu
map

明明实验做得很好,但我却发不了SCI……

2016-09-30 佚名 实验万事屋

“明明”实验做得很好,但我却始终发不了SCI。“明明”什么实验都会做,但是我还是没有一点科研思路!“明明”在实验室深受学妹们的喜爱,但我还是一个人这么久……好吧,我承认,“明明”确实要比我强……而我,啥实验都不会做……实验室在“明明”的眼里是这样的……而在我的眼里实验室是这样的……在“明明”的眼里,文献都是这样的……而在我的眼里,文献是这样的……在“明明”眼里,科研的思路是这样的……而在我的眼里,

明明”实验做得很好,但我却始终发不了SCI。“明明”什么实验都会做,但是我还是没有一点科研思路!“明明”在实验室深受学妹们的喜爱,但我还是一个人这么久……好吧,我承认,“明明”确实要比我强……而我,啥实验都不会做……



实验室在“明明”的眼里是这样的……



而在我的眼里实验室是这样的……



在“明明”的眼里,文献都是这样的……



而在我的眼里,文献是这样的……



在“明明”眼里,科研的思路是这样的……



而在我的眼里,科研思路是这样的……



我只想“静静”……



是的,我的确不如“明明”,但现实又是辣么残酷……SCI也不能不发啊……呃……


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=138028, encodeId=2b0513802860, content=正因难,才具有挑战性和意义性, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43421957843, createdName=彼岸158366, createdTime=Fri Sep 30 13:53:11 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138021, encodeId=cbaf13802195, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yqGyqlRsWYXXlASPpCvDxQIOj4U5ibyTGicNR5nTPxfE7J8CJLYEoTQiax0mdQk45PFsUH94hHxH18w/0, createdBy=96eb98305, createdName=qixiaotong123, createdTime=Fri Sep 30 13:19:44 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137978, encodeId=11f213e97845, content=换个评估标准,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:40 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137977, encodeId=291213e97720, content=确实很难,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:23 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137930, encodeId=0e2a13e93022, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Fri Sep 30 12:40:07 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137914, encodeId=7e0313e9149a, content=哈哈,明明又被黑, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Sep 30 11:04:09 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 彼岸158366

    正因难,才具有挑战性和意义性

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=138028, encodeId=2b0513802860, content=正因难,才具有挑战性和意义性, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43421957843, createdName=彼岸158366, createdTime=Fri Sep 30 13:53:11 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138021, encodeId=cbaf13802195, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yqGyqlRsWYXXlASPpCvDxQIOj4U5ibyTGicNR5nTPxfE7J8CJLYEoTQiax0mdQk45PFsUH94hHxH18w/0, createdBy=96eb98305, createdName=qixiaotong123, createdTime=Fri Sep 30 13:19:44 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137978, encodeId=11f213e97845, content=换个评估标准,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:40 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137977, encodeId=291213e97720, content=确实很难,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:23 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137930, encodeId=0e2a13e93022, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Fri Sep 30 12:40:07 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137914, encodeId=7e0313e9149a, content=哈哈,明明又被黑, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Sep 30 11:04:09 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 qixiaotong123

    呵呵

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=138028, encodeId=2b0513802860, content=正因难,才具有挑战性和意义性, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43421957843, createdName=彼岸158366, createdTime=Fri Sep 30 13:53:11 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138021, encodeId=cbaf13802195, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yqGyqlRsWYXXlASPpCvDxQIOj4U5ibyTGicNR5nTPxfE7J8CJLYEoTQiax0mdQk45PFsUH94hHxH18w/0, createdBy=96eb98305, createdName=qixiaotong123, createdTime=Fri Sep 30 13:19:44 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137978, encodeId=11f213e97845, content=换个评估标准,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:40 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137977, encodeId=291213e97720, content=确实很难,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:23 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137930, encodeId=0e2a13e93022, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Fri Sep 30 12:40:07 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137914, encodeId=7e0313e9149a, content=哈哈,明明又被黑, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Sep 30 11:04:09 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 医路开来

    换个评估标准,,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=138028, encodeId=2b0513802860, content=正因难,才具有挑战性和意义性, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43421957843, createdName=彼岸158366, createdTime=Fri Sep 30 13:53:11 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138021, encodeId=cbaf13802195, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yqGyqlRsWYXXlASPpCvDxQIOj4U5ibyTGicNR5nTPxfE7J8CJLYEoTQiax0mdQk45PFsUH94hHxH18w/0, createdBy=96eb98305, createdName=qixiaotong123, createdTime=Fri Sep 30 13:19:44 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137978, encodeId=11f213e97845, content=换个评估标准,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:40 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137977, encodeId=291213e97720, content=确实很难,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:23 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137930, encodeId=0e2a13e93022, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Fri Sep 30 12:40:07 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137914, encodeId=7e0313e9149a, content=哈哈,明明又被黑, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Sep 30 11:04:09 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 医路开来

    确实很难,,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=138028, encodeId=2b0513802860, content=正因难,才具有挑战性和意义性, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43421957843, createdName=彼岸158366, createdTime=Fri Sep 30 13:53:11 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138021, encodeId=cbaf13802195, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yqGyqlRsWYXXlASPpCvDxQIOj4U5ibyTGicNR5nTPxfE7J8CJLYEoTQiax0mdQk45PFsUH94hHxH18w/0, createdBy=96eb98305, createdName=qixiaotong123, createdTime=Fri Sep 30 13:19:44 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137978, encodeId=11f213e97845, content=换个评估标准,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:40 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137977, encodeId=291213e97720, content=确实很难,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:23 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137930, encodeId=0e2a13e93022, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Fri Sep 30 12:40:07 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137914, encodeId=7e0313e9149a, content=哈哈,明明又被黑, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Sep 30 11:04:09 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 Guoxj3234

    学习起来

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=138028, encodeId=2b0513802860, content=正因难,才具有挑战性和意义性, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43421957843, createdName=彼岸158366, createdTime=Fri Sep 30 13:53:11 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138021, encodeId=cbaf13802195, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yqGyqlRsWYXXlASPpCvDxQIOj4U5ibyTGicNR5nTPxfE7J8CJLYEoTQiax0mdQk45PFsUH94hHxH18w/0, createdBy=96eb98305, createdName=qixiaotong123, createdTime=Fri Sep 30 13:19:44 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137978, encodeId=11f213e97845, content=换个评估标准,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:40 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137977, encodeId=291213e97720, content=确实很难,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 30 12:58:23 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137930, encodeId=0e2a13e93022, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Fri Sep 30 12:40:07 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137914, encodeId=7e0313e9149a, content=哈哈,明明又被黑, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Sep 30 11:04:09 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 明月清辉

    哈哈,明明又被黑

    0

相关资讯

科学也是富人的?《自然》称科学家收入不平等在加剧

近几年,“1%”和“99%”已经成为家喻户晓的术语。它说的是美国1%的人掌握着社会上99%的财富。现在这样的问题在科学界同样存在,有显著的收入不平等问题。《自然》杂志在最新一期的封面文章中指出,科学界总体上与整个社会一样,也存收入不同等的情况。在加州大学,有医学研究员年收入超过百万美元,但博士后们的收入不到5万美元。过去几十年,精英科学家和科研苦力的收入差距在扩大。《自然》调查了3600名研究

学者首次在科技峰会上提出“科研5.0”

刚刚结束的2016年第三届诺贝尔奖获得者医学峰会暨中美院士论坛上,百替生物郭磊博士提出的全新高效科研模式 -- 科研5.0,获得了包括多位诺贝尔奖得主、中外院士等科技大咖的关注和认可。

科研新人必读:文献选择的4步骤、3识别和50字总结

导语:前几天,解螺旋发布了科研新人必读(一):如何快速通过文献关(点击标题可阅读),推荐了检索文献的方法和工具,以及如何整理文献。但是文献何其多也,如何在浩瀚的论文大海中,选择自己该读和值得读的文献,是科研新人要面对的下一个问题,今天我们要讨论就是这个问题。四类必读文献首先以下四种文献是需要阅读,且存在由浅入深的关系。1.本领域核心期刊的文献——熟悉领域不同的研究方向有不同的核心期刊,这里也不能一

临床需求导向的科学研究——真实世界研究

真实世界研究(Real-world Study, RWS)是通过不经主观筛选或二次加工的方式收集客观存在于或必然产生于日常临床诊疗实践中的数据,根据不同的待解答方向,经统计分析获得相应的研究结果,借以提供最具指导性的循证依据,正所谓“取之于民,用之于民”。RWS的要义在于“非干预”,通常采取“非随机、非对照、非设盲”的研究设计,相较于随机对照试验(Randomized Controlled T

科研狗小明心塞日记续集,总有一个命中你!

小明日记(一):实验结果与预期不符小明日记(二):实验超期小明日记(三):售后问题小明日记(四):欺负老实人小明日记(五):夸大承诺实验室的你是不是也遇到过一些槽点,或者记忆深刻的事情,欢迎分享,我们会制作成漫画的形式~~梅斯科研无忧购—您的一站式服务采购平台,提供第三方质量和资金监管,科研界的支付宝,你满意,再付钱!结果不理想怎么办?两种选择:1,我有样本,免费再做一次;2,我没有样本,申请退款

大师做研究真不把基础和条件当回事

观察周边,不难发现,常人做研究,纠结于基础和条件有余,而揪住问题和目标不足。例如,很多研究生常常以基础不好为由拒绝做有一定挑战性的选题;一些“青椒”走上新的工作岗位后,最急迫的事情是复制读博期间的科研条件,不能如愿的情况下要么坐等时光流逝、要么到处抱怨像个祥林嫂。当然,这可能与科研大环境和导向有一定关系,在我们国家,基础和条件往往很容易成为科研人员争取资源的死穴。例如,想拿基金,那基础和条件就

Baidu
map
Baidu
map
Baidu
map